Hyun-Chul Koh
Overview
Explore the profile of Hyun-Chul Koh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
14
Citations
460
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rhee Y, Ko J, Chang M, Yi S, Kim D, Kim C, et al.
J Clin Invest
. 2011 May;
121(6):2326-35.
PMID: 21576821
Parkinson disease (PD) involves the selective loss of midbrain dopamine (mDA) neurons and is a possible target disease for stem cell-based therapy. Human induced pluripotent stem cells (hiPSCs) are a...
2.
Lim Y, Lee S, Shin J, Koh H, Lee Y
J Korean Med Sci
. 2010 Jul;
25(7):1077-9.
PMID: 20592902
Functioning adrenocortical oncocytomas are extremely rare and most reported patients are 40-60 yr of age. To our knowledge, only 2 cases of functioning adrenocortical oncocytomas have been reported in childhood....
3.
Lim Y, Park E, Koh H, Lee Y
Pediatr Blood Cancer
. 2010 Mar;
54(5):734-7.
PMID: 20205255
Background: Hyponatremia is a common metabolic disorder in cancer patients. However, little information is available for patients receiving chemotherapy or stem cell transplantation (SCT). We analyzed the frequency, characteristics, and...
4.
Lee H, Bae E, Yi S, Shim J, Jo A, Kang J, et al.
Stem Cells
. 2010 Jan;
28(3):501-12.
PMID: 20049900
Effective dopamine (DA) neuron differentiation from neural precursor cells (NPCs) is prerequisite for precursor/stem cell-based therapy of Parkinson's disease (PD). Nurr1, an orphan nuclear receptor, has been reported as a...
5.
Ko J, Lee H, Park C, Koh H, Lee Y, Lee S
Mol Ther
. 2009 Jul;
17(10):1761-70.
PMID: 19603007
We have previously demonstrated derivation of neural precursor (NP) cells of a midbrain-type from human embryonic stem (hES) cells to yield an enriched population of dopamine (DA) neurons. These hES-derived...
6.
Jo A, Kim M, Lee H, Rhee Y, Lee J, Baek K, et al.
Stem Cells
. 2009 Jun;
27(9):2238-46.
PMID: 19522012
Nurr1 is a transcription factor specific for the development and maintenance of the midbrain dopamine (DA) neurons. Exogenous Nurr1 in neural precursor (NP) cells induces the differentiation of DA neurons...
7.
Kim K, Jin J, Lee Y, Choi S, Shin J, Kim J, et al.
Int J Cardiol
. 2009 Feb;
143(2):202-5.
PMID: 19203805
We hypothesized that delaying the timing of intra-coronary infusion of G-CSF mobilized stem cell until at least 4 weeks after coronary stenting should avoid the stimulation of vascular smooth muscle...
8.
Yi S, Jo A, Park C, Koh H, Park R, Suh-Kim H, et al.
Mol Ther
. 2008 Sep;
16(11):1873-82.
PMID: 18781144
Neural precursor cells (NPCs) are regarded as a promising source of donor cells in transplantation-based therapies for neurodegenerative disorders. However, poor survival and limited neuronal differentiation of the transplanted NPCs...
9.
Ko J, Park C, Koh H, Cho Y, Kyhm J, Kim Y, et al.
J Neurochem
. 2007 Sep;
103(4):1417-29.
PMID: 17854346
Human embryonic stem (hES) cells can be guided to differentiate into ventral midbrain-type neural precursor (NP) cells that proliferate in vitro by specific mitogens. We investigated the potential of these...
10.
Shim J, Park C, Bae Y, Bae J, Chung S, Chang M, et al.
Stem Cells
. 2007 Jan;
25(5):1252-62.
PMID: 17234994
Neural precursor (NP) cells from adult mammalian brains can be isolated, expanded in vitro, and potentially used as cell replacement source material for treatment of intractable brain disorders. Reduced ethical...